O-glycosyl trichloroacetimidate donor glycosylation method based on pre-activation and application of O-glycosyl trichloroacetimidate donor glycosylation method
The lack of pre-activated glycosylation of O-glycosyltrichloroacetimide ester in the prior art is solved by pre-activated reaction of O-glycosyltrichloroacetimide ester with glycosyl receptor using trifluoromethanesulfonic acid. The problem of the method has achieved a high yield and stereoselective glycosylation reaction, which is suitable for the synthesis of a variety of sugar compounds.
Patent Information
- Application Number
- CN202310596403.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-11-26
AI Technical Summary
The lack of pre-activated glycosylation methods for O-glycosyltrichloroacetimide esters in the prior art limits its application in glycochemical synthesis.
Trifluoromethanesulfonic acid (TfOH) is used as the glycosylation reaction activator, O-glycosyltrichloroacetimide ester is used as the glycosyl donor, and the glycosylation reaction is triggered through pre-activated method, and a reactive intermediate is formed by combining specific additives. , and react with glycosyl receptors to finally obtain glycosylation product.
It achieves high yield and stereoselectivity, is suitable for glycosyl donors and reactivity of a variety of different protecting groups, has excellent reactivity and stable reproducibility, is suitable for large-scale synthesis, and the reagents used are cheap and easy to obtain.
Smart Images

Figure CN119019468A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of sugar chemical synthesis, and particularly relates to a glycosidation method based on pre-activated O-glycosyl trichloroacetimidate donor and application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Glycosylation is the most critical reaction in the synthesis of carbohydrate compounds. It is the most important and common chemical reaction in sugar chain extension and sugar structural unit assembly. The stereoselectivity of glycosylation is one of the basic issues in sugar chemistry research and a huge challenge in glycosylation.
[0004] The traditional glycosylation method is to first add the glycosyl donor and the glycosyl acceptor into the reactor together, and then add the activator to carry out the glycosylation reaction. The pre-activated glycosylation method changes the order of addition. The glycosyl donor and the activator are added together first. In the absence of the glycosyl acceptor, the glycosyl donor reacts with the activator in advance to generate an active intermediate; after the activation is complete, the glycosyl acceptor is added to react to generate a new coupling product. Compared with the traditional glycosylation method, the advantages of the pre-activated glycosylation method are that, first, since the donor is activated separately, it is not necessary to carefully distinguish the relative activity of the glycosyl module as in the chemical selective method, nor is it necessary to carefully consider the selection of the leaving group and the activator as in the orthogonal method. Second, since the glycosyl acceptor reacts directly with the activated glycosyl donor, the coupling efficiency and stereoselectivity of the pre-activated glycosylation may change. Third, in the pre-activation process of the glycosyl donor, the stereo configuration of the reactive intermediate can be regulated by using additives, thereby affecting the stereo configuration of the glycosylated product. At present, the pre-activated glycosylation method has achieved the activation of a variety of sulfoglycoside-type glycosyl donors and has been successfully applied to the synthesis of chitosan, hyaluronic acid hexasaccharide and dodecasaccharide, tumor-associated carbohydrate antigen Globo-H, Lewis X and its dimer, and complex biantennary nitrogen glycoside dodecasaccharide.
[0005] As one of the most commonly used glycosyl donors, O-glycosyl trichloroacetimidate has very high reactivity and can usually achieve glycosylation reaction with high yield in a relatively wide temperature range. It is widely used in the synthesis of sugar substances such as oligosaccharides and glycoconjugates. So far, there is still no report on the pre-activated glycosylation method for O-glycosyl trichloroacetimidate. Summary of the invention
[0006] In view of the deficiencies in the prior art, the present invention provides a pre-activated O-glycosyl trichloroacetimidate donor glycosylation method and its application. The present invention uses trifluoromethanesulfonic acid (TfOH) as a glycosylation reaction activator and O-glycosyl trichloroacetimidate as a glycosyl donor, triggers the glycosylation reaction by pre-activation, and successfully obtains a glycosylated product. Based on the above research results, the present invention is completed.
[0007] Specifically, the technical solution of the present invention is as follows:
[0008] The first aspect of the present invention provides a glycosylation method based on a preactivated O-glycosyl trichloroacetimidate donor, the method comprising:
[0009] Using trifluoromethanesulfonic acid (TfOH) as a glycosylation reaction activator and O-glycosyl trichloroacetimidate as a glycosyl donor, the glycosylation reaction is triggered by pre-activation in the presence of additives to form a glycosyl donor-additive adduct (i.e., a reactive intermediate), and then a glycosyl acceptor is added for further reaction to finally obtain a glycosylation product.
[0010] The additives include but are not limited to N,N-dimethylformamide (DMF), N-formylmorpholine (NFM) and tetrabutylammonium iodide (TBAI).
[0011] The second aspect of the present invention provides the use of the above-mentioned glycosylation method based on pre-activated O-glycosyl trichloroacetimidate donor in the synthesis of carbohydrate compounds.
[0012] Beneficial effects of one or more of the above technical solutions:
[0013] 1. High yield and stereoselectivity. In the glycosylation method based on the preactivated O-glycosyl trichloroacetimidate donor of the present invention, through the preactivated feeding mode and the regulation of the additive, the α- or β-configuration glycosyl donor can provide high stereoselectivity with α-configuration as the main component, and obtain a high yield of glycosylated products.
[0014] 2. Excellent reactivity and wide application range of substrates. The glycosylation method of the present invention based on pre-activated O-glycosyl trichloroacetimidate donor has excellent reactivity and stereoselectivity for glycosyl donors with various protective groups, primary hydroxyl groups, secondary hydroxyl groups and sugar alcohol glycosyl acceptors with different reactivity.
[0015] 3. Stable reproducibility. The glycosylation method of the present invention based on the preactivated O-glycosyl trichloroacetimidate donor can still obtain a considerable reaction yield and stereoselectivity in gram-level and decagram-level reaction scales, and can be used for large-scale and highly economical synthesis of target molecules.
[0016] 4. The reaction conditions are mild and controllable, and the reagents and raw materials are cheap and readily available. The present invention is based on the glycosylation method of pre-activated O-glycosyl trichloroacetimidate donor, and the activators and additives (such as TfOH, DMF, TBAI, etc.) used are all common commercial reagents, which are cheap and readily available, providing a good foundation for the wide application of the method, and therefore has good practical application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] The drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present application. The illustrative embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0018] Figure 1 : NMR spectrum of compound 17;
[0019] Figure 2 : NMR spectrum of compound 18;
[0020] Figure 3 : NMR spectrum of compound 20;
[0021] Figure 4 : NMR spectrum of compound 27;
[0022] Figure 5 : NMR spectrum of compound 28;
[0023] Figure 6 : NMR spectrum of compound 30;
[0024] Figure 7 : NMR spectrum of compound 33. DETAILED DESCRIPTION
[0025] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0026] It should be noted that the "equivalent" in the present invention refers to the ratio of the amounts of substances when substances interact with each other, such as: acceptor (1.5 equivalents), donor (1.0 equivalents) means that the amount ratio of the acceptor compound to the donor compound in the reaction is 1.5:1.
[0027] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, it will be described in detail below in conjunction with specific embodiments.
[0028] In a typical embodiment of the present invention, a method for glycosidation of a preactivated O-glycosyl trichloroacetimidate donor is provided, the method comprising:
[0029] Using trifluoromethanesulfonic acid (TfOH) as a glycosylation reaction activator and O-glycosyl trichloroacetimidate as a glycosyl donor, the glycosylation reaction is triggered by pre-activation in the presence of additives to form a glycosyl donor-additive adduct (i.e., a reactive intermediate), and then a glycosyl acceptor is added for further reaction to finally obtain a glycosylation product.
[0030] The additives include but are not limited to N,N-dimethylformamide (DMF), N-formylmorpholine (NFM) and tetrabutylammonium iodide (TBAI).
[0031] It should be noted that although the above-mentioned glycosyl donor takes O-glycosyl trichloroacetimidate as an example, other hydroxyl groups of the glycosyl donor can be replaced by different protective groups or connected to other structural units; specifically, the glycosyl donor can be an α- or β-configuration glycosyl donor, and can include compounds 1-9;
[0032] The glycosyl acceptor includes but is not limited to glycosyl compounds with primary hydroxyl groups, secondary hydroxyl groups and sugar alcohols with a monohydroxyl structure; specifically, the glycosyl acceptor may include compounds 10-16:
[0033]
[0034] Among them, Bn is benzyl, TBDPS is tert-butyldiphenylsilyl, Lev is levulinyl, PMB is p-methoxybenzyl, Ph is phenyl, TBS is tert-butyldimethylsilyl, All is allyl, Bz is benzoyl, Tol is tolyl, and Me is methyl.
[0035] In another specific embodiment of the present invention, the method comprises carrying out a glycosidation reaction with an O-glycosyl trichloroacetimidate donor, a primary hydroxyl compound (or a compound having a reactive activity equivalent to that of a primary hydroxyl group), and a sugar alcohol glycosyl acceptor;
[0036] The specific method includes: adding the activator TfOH to an anhydrous dichloromethane (DCM) solution containing a glycosyl donor, N,N-dimethylformamide (DMF) and molecular sieves under an extremely low temperature inert gas environment, stirring until the glycosyl donor is completely converted, adding tetrabutylammonium iodide (TBAI) under a low temperature inert gas environment until glycosyl iodide is completely generated, and then adding a glycosyl acceptor; heating and continuing stirring until the reaction is complete; and purifying to obtain the corresponding glycosylation product.
[0037] Among them, the extremely low temperature is -70℃ and below, such as -70℃, -71℃, -72℃, -73℃, -74℃, -75℃, -76℃, -77℃, -78℃, -79℃ and -80℃.
[0038] The low temperature can be -10 to 4°C, such as -10°C, -9°C, -8°C, -7°C, -6°C, -5°C, -4°C, -3°C, -2°C, -1°C, 0°C, 1°C, 2°C, 3°C and 4°C, etc.
[0039] The molar ratio of TfOH, glycosyl donor, N,N-dimethylformamide, tetrabutylammonium iodide and glycosyl acceptor is 1:1:10-20:1-10:0.8-1.5.
[0040] The heating temperature is to 30-40°C, such as 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C and 40°C.
[0041] Wherein, the molecular sieve can be MS molecular sieve, the concentration is 50-150 mg / ml;
[0042] The concentration of the anhydrous dichloromethane solution is 0.05-0.1M.
[0043] The purification steps include: diluting with DCM, filtering out the precipitate through a celite pad; rinsing the filtrate with NaHCO 3 (aq.), Na 2 S 2 O 3 (aq.) and NaCl (aq.), and washed with Na 2 SO 4 Dry, filter and remove the solvent under reduced pressure; the resulting residue is purified by silica gel column chromatography to give the corresponding glycosylated product.
[0044] In another specific embodiment of the present invention, in the reaction example of the glycosylation scheme, at least one of compounds 1-7, 9 is used as a glycosyl donor, and at least one of the above-mentioned primary hydroxyl compounds 12, 14 and sugar alcohols 10, 11 is used as an acceptor, and a high coupling yield and high α-selectivity are obtained. Even for acceptors containing secondary hydroxyl groups and having low reactivity due to steric hindrance, the reaction can proceed well.
[0045] The results of the glycosylation reaction are shown below:
[0046]
[0047] In another specific embodiment of the present invention, in the reaction example of the glycosylation scheme, at least one of the above compounds 1, 3, 6, 8, and 9 is used as a glycosyl donor, and at least one of the above secondary hydroxy compounds 13, 15, and 16 is used as a glycosyl acceptor to obtain a glycosylation product that is mainly α-selective. The glycosylation reaction results are shown below:
[0048]
[0049] In another specific embodiment of the present invention, there is provided application of the above-mentioned glycosylation method based on pre-activated O-glycosyl trichloroacetimidate donor in the synthesis of carbohydrate compounds.
[0050] Specifically, the application includes the construction of O-glycosidic bonds in carbohydrate compounds to achieve the extension of sugar chains.
[0051] The present invention is further explained by the following examples, but it is not intended to limit the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In the following specific embodiments, all reactions are carried out under positive argon pressure using flame-dried modified Schlenk flasks equipped with glass stoppers or rubber septa. The reaction progress is tracked by thin layer chromatography (TLC) and detected by fluorescence and / or acidic cerium ammonium molybdate staining.
[0052] Example
[0053] 1. In this example, glycosylated products 17-26 were prepared according to the following procedure:
[0054]
[0055] The glycosylation reaction of the glycosyl acceptor being a primary hydroxyl compound or a sugar alcohol compound was carried out using the standard reaction procedure (1): under an inert gas environment at -78°C, the activator TfOH (1.0 equivalent) was added to a solution containing a glycosyl donor (1.0 equivalent), dry DMF (15.0 equivalent) and dry MS (100 mg / ml) in anhydrous DCM solution (0.075 M) was stirred. After the glycosyl donor was completely converted by TLC plate, TBAI (5.0 equivalents) was added under an inert gas environment at 0°C. After the glycosyl iodide was completely generated by TLC plate, the glycosyl acceptor (1.5 equivalents or 0.8 equivalents) was added. Stirring was continued at 35°C until the reaction was complete. Et 3 The reaction was quenched with N, diluted with DCM, and the precipitate was filtered off through a celite pad. The filtrate was washed with NaHCO 3 (aq.), Na 2 S 2 O 3 (aq.) and NaCl (aq.), and washed with Na 2 SO 4 After drying, filtering and removing the solvent under reduced pressure, the obtained residue was purified by silica gel column chromatography to obtain the corresponding glycosylated product.
[0056] 1.1 Preparation of glycosylated product 17
[0057] The standard procedure (1) was used to glycosylate the glycosyl donor 1 (14.0 g, 20.0 mmol) with the glycosyl acceptor 10 (3.86 g, 16.4 mmol) to give the products 17α (10.0 g, 80%) and 17β (530 mg, 4%) as colorless oils. 1 HNMR of 17α(400MHz,CDCl 3 )δ=8.03(d,J=7.7Hz,2H,ArH),7.51(t,J=7.4Hz,1H,ArH),7.42–7.14(m,22H,A rH),5.86(ddt,J=16.3,10.8,5.5Hz,1H,CH2CH=CH2),5.25(dd,J=17.2,1.8Hz,1 H,CH2CH=CH2),5.20(d,J=3.7Hz,1H,1-H),5.15(d,J=10.5Hz,1H,CH2CH=CH2),4 .90(d,J=11.4Hz,1H,PhCH2),4.81(d,J=12.0Hz,1H,PhCH2),4.78(d,J=12.0Hz, 1H,PhCH2),4.71(d,J=11.8Hz,1H,PhCH2),4.70(d,J=11.6Hz,1H,PhCH2),4.55 –4.49(m,2H,PhCH2,1”-H),4.43(dd,J=11.7,6.1Hz,1H,1”-H),4.32(d,J=11.8H z,1H,PhCH2),4.25(d,J=11.8Hz,1H,PhCH2),4.22–4.17(m,1H,2”-H),4.14(t,J =6.8Hz,1H,5-H),4.06(dd,J=9.5,3.6Hz,1H,2-H),4.02–3.90(m,4H,CH2CH=CH2 X 2, 3-H, 4-H), 3.69–3.59 (m, 2H, 3”-H 13 C NMR of 17α(100MHz,CDCl 3)δ=166.16,138.73,138.58,138.57,137.90,134.34,132.83,129.92,1 29.52,128.25,128.17,128.14,128.03,127.99,127.70,127.49,127.4 1,127.34,127.27,116.97,97.12,78.69,76.15,74.85,74.67,74.03,7 3.19,72.89,72.84,72.22,69.55,69.35,68.51,64.96.HRMS(ESI)Calcd for C 47 H 54 NO 9 [M+NH 4 ] + :776.3793,found:776.3804.
[0058] 1.2 Preparation of glycosylated product 18
[0059] The standard operating procedure (1) was used: the glycosyl donor 4 (12.0 g, 16.6 mmol) was glycosylated with the glycosyl acceptor 11 (1.6 mL, 13.3 mmol) to obtain the product 18 (7.6 g, 83%, α / β>20 / 1) as a colorless oil. 1 H NMR (400 MHz, CDCl 3)δ=7.33–7.14(m,15H,ArH),6.83–6.73(m,2H,ArH),4.91(d,J=10.8Hz,1H,PhCH2),4.80( d,J=10.8Hz,1H,PhCH2),4.72(d,J=10.8Hz,1H,PhCH2),4.71(d,J=3.6Hz,1H,1-H),4.63( d,J=11.6Hz,1H,PhCH2),4.52(d,J=10.8Hz,1H,PhCH2),4.49(d,J=10.4Hz,1H,PhCH2),4. 28(t,J=6.0Hz,1H,2”-H),4.25–4.14(m,2H,6-H,6’-H),4.00(dd,J=8.4,6.3Hz,1H,1”-H), 3.88(t,J=9.2Hz,1H,3-H),3.81–3.74(m,1H,5-H),3.72(s,3H,OMe),3.66(dd,J=8.4,6.1 Hz,1H,1”-H),3.53(dd,J=10.6,5.8Hz,1H,3”-H),3.47(dd,J=10.6,5.8Hz,1H,3”-H),3.44 (dd,J=9.6,3.6Hz,1H,2-H),3.39(dd,J=10.0,8.8Hz,1H,4-H),2.64(q,J=6.4,5.9Hz,2H, CH2),2.49(t,J=6.6Hz,2H,CH2),2.08(s,3H,CH2),1.34(s,3H,CH3),1.29(s,3H,CH3).13C NMR (100MHz, CDCl3)δ=206.13,172.41,159.36,138.65,137.87,130.18,129.55,128.39,128.35,128.05,127.88,127.80,127.57,113.83,109 .40,97.27,81.75,79.57,75.62,75.03,74.51,72.64,69.04,68.82,66.92,63.15,55.21,37.78,29.76,27.74,26.81,25.42.HRMS(ESI)Calcd for C 39 H 52 NO 11 [M+Na] + :710.3535,found:710.3531.
[0060] 1.3 Preparation of glycosylated product 20
[0061] The standard operating procedure (1) was adopted: the glycosylation reaction of glycosyl donor 1 (50 mg, 73 μmol) and glycosyl acceptor 14 (27 mg, 58 μmol) was carried out to obtain product 20 (48.5 mg, 85%, α / β>20 / 1) in a solid-like form. The obtained NMR spectrum was consistent with that reported in the literature.
[0062] In the present invention, 27-35 is prepared according to the following operating procedure:
[0063]
[0064] The glycosylation reaction of the glycosyl acceptor as a secondary hydroxyl compound was carried out using the standard operating procedure (2): under an inert gas environment at -78°C, the activator TfOH (1.0 equivalent) was added to a solution containing the glycosyl donor (1.0 equivalent), dry DMF (15.0 equivalent) and dry MS (100 mg / ml) in anhydrous DCM solution (0.075 M) was stirred. After the glycosyl donor was completely converted as detected by TLC plate, the glycosyl acceptor (0.8 equivalent) was added. Stirring was continued at 35°C until the reaction was complete. Et 3 The reaction was quenched with N, diluted with DCM, and the precipitate was filtered off through a celite pad. The filtrate was washed with NaHCO 3 (aq.) and NaCl (aq.), and washed with Na 2 SO 4 After drying, filtering and removing the solvent under reduced pressure, the obtained residue was purified by silica gel column chromatography to obtain the corresponding glycosylated product.
[0065] 2.1 Preparation of glycosylated product 27
[0066] The standard operating procedure (2) was adopted: 1 (50 mg, 73 μmol) was glycosylated with 13 (27 mg, 58 μmol) to obtain 27 (48.8 mg, 86%, α / β>20 / 1) in a solid-like form. The obtained NMR spectrum was consistent with that reported in the literature.
[0067] 2.2 Preparation of glycosylated product 28
[0068] The standard operating procedure (2) was adopted: 1 (50 mg, 73 μmol) was glycosylated with 16 (27 mg, 58 μmol) to obtain 28 (43.0 mg, 84%, α / β>20 / 1) in a solid-like form. The obtained NMR spectrum was consistent with that reported in the literature.
[0069] 2.3 Preparation of glycosylated product 30
[0070] The standard operating procedure (2) was adopted: 3 (30 mg, 44 μmol) was glycosylated with 13 (16.3 mg, 35 μmol) to obtain 30 (29.4 mg, 85%, α / β>20 / 1) in a solid-like form. The obtained NMR spectrum was consistent with that reported in the literature.
[0071] 2.4 Preparation of glycosylated product 33
[0072] The standard operating procedure (2) was adopted: 8 (50 mg, 84 μmol) was glycosylated with 16 (25.1 mg, 67 μmol) to obtain 33 (45.9 mg, 85%, α / β>20 / 1) in a solid-like form. The obtained NMR spectrum was consistent with that reported in the literature.
[0073] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A glycosylation method based on a preactivated O-glycosyl trichloroacetimidate donor, characterized in that: The method comprises: Using trifluoromethanesulfonic acid as a glycosylation reaction activator and O-glycosyl trichloroacetimidate as a glycosyl donor, in the presence of an additive, a glycosylation reaction is triggered by a pre-activation method to form a glycosyl donor-additive adduct, and then a glycosyl acceptor is added for further reaction to finally obtain a glycosylation product; Wherein, the additives include N,N-dimethylformamide, N-formylmorpholine and tetrabutylammonium iodide.
2. The method according to claim 1, characterized in that The glycosyl donor includes compounds 1-9; The glycosyl acceptor includes glycosyl compounds with primary hydroxyl groups, secondary hydroxyl groups, and sugar alcohols with a monohydroxyl structure; specifically, the glycosyl acceptor includes compounds 10-16; 3. The method according to claim 1, characterized in that The method comprises the steps of carrying out glycosidation reaction with an O-glycosyl trichloroacetimidate donor, a primary hydroxyl compound (or a compound having a reactive activity equivalent to that of a primary hydroxyl group) and a sugar alcohol glycosyl acceptor.
4. The method according to claim 3, characterized in that include: The activator TfOH is added to an anhydrous dichloromethane solution containing a glycosyl donor, N,N-dimethylformamide and a molecular sieve under an extremely low temperature inert gas environment, and stirred until the glycosyl donor is completely converted. Then, tetrabutylammonium iodide is added under a low temperature inert gas environment until glycosyl iodide is completely generated, and then a glycosyl acceptor is added; the temperature is raised and stirring is continued until the reaction is complete; and the corresponding glycosylation product is obtained after purification.
5. The method according to claim 4, characterized in that The extremely low temperature is -70°C and below; the low temperature is -10 to 4°C.
6. The method according to claim 4, characterized in that The molar ratio of TfOH, glycosyl donor, N,N-dimethylformamide, tetrabutylammonium iodide and glycosyl acceptor is 1:1:10-20:1-10:0.8-1.
5.
7. The method according to claim 4, characterized in that The heating temperature is raised to 30-40°C.
8. The method according to claim 4, characterized in that The molecular sieve is MS molecular sieve, the concentration is 50-150 mg / ml; The concentration of the anhydrous dichloromethane solution is 0.05-0.1M.
9. The method according to claim 4, characterized in that The purification steps include: diluting with DCM, filtering out the precipitate through a celite pad; washing the filtrate with NaHCO3, Na2S2O3 and NaCl, and drying with Na2SO4, filtering and removing the solvent under reduced pressure distillation; and purifying the resulting residue by silica gel column chromatography to obtain the corresponding glycosylated product.
10. Application of the glycosylation method based on preactivated O-glycosyl trichloroacetimidate donor according to any one of claims 1 to 9 in the synthesis of carbohydrate compounds; further, the application includes the construction of O-glycosidic bonds in carbohydrate compounds to achieve sugar chain extension.
